Teva, one of the biggest generic makers, joins the the brand-name club
Teva follows AbbVie to leave top pharma industry group (NYSE:TEVA) | Seeking Alpha
Teva sells Overland Park business segment - Kansas City Business Journal
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate' | Markets Insider
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical Industries — 9 Portfolio companies, 10 Investments, Team — Unicorn Nest
Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva halts production at sterile injectables plant to address FDA concerns | Fierce Pharma
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Teva Pharmaceuticals - Wikipedia
Teva moving U.S. HQ (and 832 high-paying jobs) to Parsippany | ROI-NJ
Israel-Based Teva Pharmaceutical Industries Smacks Down With Mylan With $40B Bid - YouTube
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceuticals Office Photos | Glassdoor
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
Teva Israel enters medical cannabis market with new partnership | Reuters
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
